Abstract
Background
Thrombocytopenia is a frequent finding among ill returned travellers and may be caused by a large number of different conditions, including infectious diseases specific or typical for tropical and subtropical regions. In order to assess the diagnostic significance of thrombocytopenia we investigated a large cohort of returned travellers.
Methods
This was a comparative study in which data collected on 19,473 returned travellers who consulted the outpatient travel clinic of the the University of Munich Hospital between 1999 and 2009 were analysed. Of these, 732 (3.8%) travellers were diagnosed with thrombocytopenia, and their data were compared with those of the remaining 18,741 travellers with normal platelet counts.
Results
Thrombocytopenia was significantly more frequent among patients with malaria (63%), acute human immunodeficiency virus infection (48%), dengue fever/dengue haemorrhagic fever (DF/DHF; 47%), Epstein–Barr virus infectious mononucleosis (23%), paratyphoid/typhoid fever (14%), and rickettsiosis (12%). Malaria and DF/DHF caused 25% of all cases of thrombocytopenia (platelet count <140,000/μl) and 75% of all cases of severe thrombocytopenia (platelet count <30,000/μl). Sex, age, country of origin, duration and type of travel were not significantly correlated with thrombocytopenia. The most frequent travel destinations were Asia (42%), Africa (33%), and Latin America (14%). Travellers to Sub-Saharan Africa (high risk for malaria) and to South/South-east Asia (high risk for DF/DHF) had the highest relative risk for thrombocytopenia.
Conclusion
Platelet count among returned travellers is an essential screening parameter, as thrombocytopenia is highly correlated with important infectious diseases, particularly with malaria and DF/DHF.
Similar content being viewed by others
References
Fleming AF, de Silva PS. Haematological diseases in the tropics. In: Manson’s tropical diseases. Elsevier WB Saunders, 2003;174.
George JN. Platelets. Lancet. 2000;355:1531–9.
Dolan TT. Thrombocytopenia in experimental babesiosis. Trans R Soc Trop Med Hyg. 1974;68:274.
Kettner F, Reyers F, Miller D. Thrombocytopenia in canine babesiosis and its clinical usefulness. J S Afr Vet Assoc. 2003;74:63–8.
Costa CH, Werneck GL, Costa DL, Holanda TA, Aguiar GB, Carvalho AS, Cavalcanti JC, Santos LS. Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Rev Soc Bras Med Trop. 2010;43:386–92.
Gürkan E, Başlamişli F, Güvenç B, Bozkurt B, Unsal C. Immune thrombocytopenic purpura associated with Brucella and Toxoplasma infections. Am J Hematol. 2003;74:52–4.
Tuon F, Higashino HR, Amato VS, Nicodemo AC. Acute immune-mediated thrombocytopenic purpura related to Toxoplasma gondii infection. Int J Infect Dis. 2008;12:671–2.
Robins-Browne RM, Schneider J, Metz J. Thrombocytopenia in trypanosomiasis. Am J Trop Med Hyg. 1975;24:226–31.
Davis CE. Thrombocytopenia: a uniform complication of African trypanosomiasis. Acta Trop. 1982;39:123–33.
Tribulatti MV, Mucci J, Van Rooijen N, Leguizamón MS, Campetella O. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas’ disease by reducing the platelet sialic acid contents. Infect Immun. 2005;73:201–7.
Jadhav UM, Patkar VS, Kadam NN. Thrombocytopenia in malaria—correlation with type and severity of malaria. J Assoc Physicians India. 2004;52:615–8.
Shaik QH, Ahmad SM, Abbasi A, Malik SA, Sahito AA, Muni SM. Thrombocytpenia in malaria. J Coll Physicians Surg Pak. 2009;19:708–10.
Schexneider KI, Reedy EA. Thrombocytopenia in dengue fever. Curr Hematol Rep. 2005;4:145–8.
Bandyopadhyay S, Lum LC, Kroeger A. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health. 2006;11:1238–55.
Scaradavou A. HIV-related thrombocytopenia. Blood Rev. 2002;16:73–6.
Sundell IB, Koka PS. Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression. Curr HIV Res. 2006;4:107–16.
Marks KM, Clarke RM, Bussel JB, Talal AH, Glesby MJ. Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;52:595–9.
Steeper TA, Horwitz CA, Moore SB, Henle W, Henle G, Ellis R, Flynn PJ. Severe thrombocytopenia in Epstein–Barr virus-induced mononucleosis. West J Med. 1989;150:170–3.
Likic R, Kuzmanic D. Severe thrombocytopenia as a complication of acute Epstein–Barr virus infection. Wien Klin Wochenschr. 2004;116:47–50.
Rasche FM, Uhel B, Krüger DH, Karges W, Czock D, Hampl W, Keller F, Meisel H, von Müller L. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis. 2004;10:1420–5.
Denecke B, Bigalke B, Haap M, Overkamp D, Lehnert H, Haas CS. Hantavirus infection: a neglected diagnosis in thrombocytopenia and fever? Mayo Clin Proc. 2010;85:1016–20.
Fisgin T, Yarali N, Duru F, Kara A. CMV-induced immune thrombocytopenia and excessive hematogones mimicking an acute B-precursor lymphoblastic leukemia. Leuk Res. 2003;27:193–6.
Pantanowitz L. Mechanisms of thrombocytopenia in tick-borne diseases. The Internet J Infect Dis. Available at: http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijid/vol2n2/tick.xml (2003). Accessed 12 June 2011.
Pancholi P, Kolbert CP, Mitchell PD, Reed KD Jr, Dumler JS, Bakken JS, Telford SR 3rd, Persing DH. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis. 1995;172:1007–12.
Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R. Mediterranean spotted fever: a review of fifteen cases. J Dermatol. 2006;33:103–7.
Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A, Sexton DJ, Buckingham SC, Marshall GS, Storch GA, Dasch GA, McQuiston JH, Swerdlow DL, Dumler SJ, Nicholson WL, Walker DH, Eremeeva ME, Tickborne Rickettsial Diseases Working Group; CDC. Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever, ehrlichioses, and anaplasmosis—United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006;55:1–27.
Faierman D, Ross FA, Seckler SG. Typhoid fever complicated by hepatitis, nephritis, and thrombocytopenia. JAMA. 1972;221:60–1.
Hustinx WN, Nio Y, Speelman P. Abdominal typhus and paratyphoid fever in 2 academic hospitals: 1984–1990. (in Dutch) Ned Tijdschr Geneeskd. 1993;137:291–4.
Alugupulli KR, Michelson AD, Joris I, Schwan TG, Hodivala-Dilke K, Hynes RO, Leong JM. Spirochete–platelet attachment and thrombocytopenia in murine relapsing fever borreliosis. Blood. 2003;102:2843–50.
Nicodemo AC, Negro del G, Amato Neto V. Thrombocytopenia and leptospirosis. Rev Inst Med Trop São Paulo. 1990;32:252–9.
Wagenaar JF, Goris MC, Partiningrum DL, Isbandrio B, Hartskeerl RA, Brandjes DP, Meijers JC, Gasern MH, van Gorp EC. Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop Med Int Health. 2010;15:152–9.
Juhlin L. Early congenital syphilis and thrombocytopenia. Acta Derm Venereol. 1968;48:166–9.
Di Mario A, Sica S, Zini G, Salutari P, Leone G. Microangiopathic hemolytic anemia and severe thrombocytopenia in Brucella infection. Ann Hematol. 1995;70:59–60.
Altuntas F, Eser B, Sari I, Yildiz O, Cetin M, Unal A. Severe thrombotic microangiopathy associated with brucellosis: successful treatment with plasmapheresis. Clin Appl Thromb Hemost. 2005;11:105–8.
Guo YL, Liu DQ, Bian Z, Zhang CY, Zen K. Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia. PLoS One. 2009;4:e7131.
Acknowledgements
The authors thank all patients in this study for their cooperation.
Conflict of interest
None of the authors had any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herbinger, KH., Schunk, M., Nothdurft, H.D. et al. Comparative study on infection-induced thrombocytopenia among returned travellers. Infection 40, 373–379 (2012). https://doi.org/10.1007/s15010-012-0242-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-012-0242-9